More Sun Pharmaceutical Industries Limited news
Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Press Release Sep 06 2024

Sep 6, 2024 at 12:12 PM EDT · Issued by Sun Pharmaceutical Industries Limited

Filed with NSE · Sep 6, 2024 at 12:12 PM EDT

On 6ix: 6ix.com/news/press-release-sep-06-2024-1

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 06, 2024

View Attachment

6ix hasn’t read this filing yet.

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

  • Press Release Aug 23 2024Aug 23, 2024
  • Press Release Jul 26 2024Jul 26, 2024
  • Press Release Jul 16 2024Jul 16, 2024
  • Press Release Jul 04 2024Jul 4, 2024
  • Press Release Jun 24 2024Jun 24, 2024

Later from Sun Pharmaceutical Industries

  • Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee PainSep 9, 2024
  • Press Release Sep 26 2024Sep 26, 2024
  • Press Release Oct 01 2024Oct 1, 2024
  • Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for commercializing the specialty product FIBROMUNOct 2, 2024
  • Press Release Oct 15 2024Oct 15, 2024
All Sun Pharmaceutical Industries news releases↗

Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.

Follow Sun Pharmaceutical Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer